Melanoma Posts Page 2 on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

Does Sentinel Lymph Node Biopsy Increase Survival in Patients with Thick Melanoma?

Posted by on Jul 16, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether Sentinel Lymph Node (SLN) biopsy increases survival in patients with thick melanoma. The study found that SLN biopsy was associated with an increase in disease free survival (DFS) in patients with melanoma. Some background Sentinel lymph node (SLN) biopsy is used to identify whether tumour has started...

Read More

Have survival rates improved for patients treated for Metastasis from Uveal Melanoma?

Posted by on Jul 16, 2018 in Melanoma | 0 comments

In a nutshell This study investigated if there has been an improvement in survival after treatment in patients with metastasis from uveal melanoma. The study found no significant improvement in survival rates in patients who were treated for metastasis from uveal melanoma. Some background Despite successful treatment of tumors in patients who are...

Read More

Can white blood cell count be used to predict if cancer will reoccur in patients with melanoma?

Posted by on Jul 16, 2018 in Melanoma | 0 comments

In a nutshell This study investigated if there was a relationship between Neutrophil-to-Lymphocyte ratio (NLR) and cancer recurrence (cancer coming back) in patients with melanoma. The results found that a high NLR was a strong predictor for disease recurrence in patients with melanoma. Some background Neutrophil and lymphocytes are white...

Read More

Does body-mass index (BMI) affect survival in patients with metastatic melanoma?

Posted by on Jul 3, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether body-mass index (BMI) had any effect on survival in patients with metastatic melanoma who received targeted therapy, immunotherapy, or chemotherapy. The study found that male metastatic melanoma patients who had a high BMI had improved survival compared to patients with normal BMI. Some background Targeted...

Read More

Have targeted therapies improved the survival of patients with melanoma brain metastases

Posted by on Jun 28, 2018 in Melanoma | 0 comments

In a nutshell This study investigated whether the risk of developing melanoma brain metastases (MBM) and survival among patients with MBM has changed since the introduction of more effective therapies. The results found the overall survival for patients with MBM has improved significantly since 2011. Some background In more than 33% of patients...

Read More

PET is effective detecting recurrences in stage 3 melanoma

Posted by on Jun 4, 2018 in Melanoma | 0 comments

In a nutshell This study investigated the effectiveness of the imaging method PET (detects active cancer lesions) in detecting relapses after surgery in stage 3 melanoma patients. Researchers suggested that PET allows the detection of most recurrences. Some background Stage 3 melanoma is associated with a high rate of recurrences. Follow-up of...

Read More